Open the mobile version, with barcode scanning
Class III Ongoing

Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02

Why: Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

Company
Eugia US LLC
East Windsor, NJ, United States
Reported
Jun 10, 2026
Recall started
May 18, 2026
Where sold
US Nationwide.
Amount
168,300 vials
Full product description
Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02
Lots / codes affected
Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.